New Phase III stem cell study for treatment of back pain associated with degenerative disc disease

Written by Elena Conroy

Denver Back Pain Specialists (CO, USA) announces commencement of nationwide FDA-cleared Phase III study of mesenchymal precursor cells for chronic low back pain associated with degenerative disc disease Denver Back Pain Specialists (CO, USA) announced that it has enrolled its first patient in a nationwide FDA-cleared Phase III adult stem cell study to test a treatment for chronic low back pain associated with degenerative disc disease. The study will test the use of mesenchymal precursor cells (MPCs) — adult stem cells derived from bone marrow that will be directly injected into the lumbar disc. An estimated 30 million people in...

To view this content, please register now for access

It's completely free